Synthia

  • Login
  • Subscribe
  • Connect
...
  1. Home
  2. Impact
  3. Publications
  4. Synth4bench: Synthetic Data Generation for Benchmarking Tumor-Only Somatic Variant Calling Algorithms
  • SYN-Y2-2025-015: Publication [Fragkouli et al., The Centre for Research & Technology Hellas] 
  • bioRxiv, October 2025. Read here> 
  • Somatic variant calling lacks high-quality ground truth datasets, making tool evaluation difficult. To address this, the authors developed synth4bench, a synthetic data pipeline that generates controlled benchmarking datasets. Using these data, we systematically evaluated five tumor-only variant callers (Mutect2, FreeBayes, VarDict, VarScan2, LoFreq) across varying sequencing conditions. The results show substantial inconsistencies between callers and a strong dependence on sequencing depth and read length. Indels remain the most challenging variants, particularly at low allele frequencies. Caller performance reflected underlying algorithmic choices: the most robust tools showed superior precision in allele frequency estimates, while the most sensitive maximized true-positive detection. The weakest performer displayed systematic errors and the lowest overall accuracy. Overall, no single caller fits all scenarios; optimal sequencing design and careful tool selection are essential. The variability observed also indicates that current algorithms still fall short of fully modeling the complexity of mutational processes.

Related Impact Highlights

Discover outputs and activities connected to this use case, highlighting the research, collaboration, and dissemination efforts driving progress in SYNTHIA.

Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

Use Cases

Multiple Myeloma

Multiple Myeloma

Use Cases

      Synthia

      Synthetic Data Generation framework for integrated validation of use cases and Al healthcare applications.

      This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101172872. The JU receives support from the European Union's Horizon Europe research and innovation programme, COCIR, EFPIA, Europa Bío, MedTech Europe, Vaccines Europe and DNV. The UK consortium partner, The National Institute for Health and Care Excellence (NICE) is supported by UKRI Grant 10132181.

      © SYNTHIA 2025. Legal Notices.

      Follow us

       

      ihi-synthiaihi-synthia@ihi-synthia@ihi-synthia@IHI_SYNTHIA@IHI_SYNTHIA@ihi-synthia@ihi-synthiaSYNTHIA RewiredSYNTHIA Rewired

      Contact us

       

      www.ihi-synthia.eu

      contact@ihi-synthia.eu